drugset / Trial / NCT02489227
Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a 3-period study comparing CHS-1420 to Humira in patients with chronic plaque psoriasis.
Timeline
- Start
- 2015-08
- Primary completion
- 2016-05-06
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adalimumab | Monoclonal antibody | 40 mg | — |
| Subject | CHS-1420 | Unknown | 40 mg | — |